PubMed Health⌕ Search

Biomedical subjects

Anthony D Ormerod

Publications and source records attributed to Anthony D Ormerod.

4 recordsLinked to original sources
PubMed2005

A multicentre review of the hairdressing allergens tested in the UK.

Allergens used for patch testing in the hairdressing series vary between dermatology centres in the UK. The aim of our study is to ascertain the hairdressing allergens currently in use and their test results in several dermatology centres in the UK. Data were obtained from databases in 9 dermatology departments. The allergens with positive results and current/past relevance were included in a new hairdressing series based on collective experience, for wider use and further evaluation.

Allergens↗
PubMed2005

A multicentre review of the footwear allergens tested in the UK.

Footwear allergens used for patch testing vary between dermatology centres in the UK. The aim of our study is to ascertain the footwear allergens currently in use and their test results in several dermatology centres in the UK. Data were obtained from databases in 9 dermatology departments. A new footwear series consisting of 19 allergens including those with positive results and current/past relevance in this study based on collective experience is proposed for wider use and further evaluation.

Allergens↗
PubMed2003

Alefacept. Biogen.

Alefacept is a lymphocyte function-associated antigen-3/IgG1 fusion protein that inhibits T-cells by antagonizing CD2, which has been developed and launched by Biogen for the potential treatment of psoriasis. In February 2003, Biogen launched alefacept in the US for use in adults with moderate-to-severe chronic plaque psoriasis, and by March 2003, the company was preparing for psoriasis trials to commence in Japan by the end of December 2003.

Alefacept↗